Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study

被引:0
作者
Marianna Amboni
Luigi Iuppariello
Alessandro Iavarone
Alfonso Fasano
Raffaele Palladino
Rosaria Rucco
Marina Picillo
Ilaria Lista
Pasquale Varriale
Carmine Vitale
Mario Cesarelli
Giuseppe Sorrentino
Paolo Barone
机构
[1] University of Salerno,Department of Medicine and Surgery “Scuola Medica Salernitana”, Center for Neurodegenerative Diseases
[2] Istituto di Diagnosi e Cura Hermitage-Capodimonte,DIETI
[3] University of Naples,Department of Pediatric Rehabilitation
[4] “Federico II”,Neurological and Stroke Unit
[5] Santobono-Pausilipon Children’s Hospital,Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Division of Neurology, Toronto Western Hospital, UHN
[6] Centro Traumatologico Ortopedico Hospital AORN “Ospedali dei Colli”,Department of Primary Care and Public Health
[7] University of Toronto,Department of Public Health
[8] Krembil Research Institute,Department of Motor Sciences and Wellness
[9] Imperial College,undefined
[10] University of Naples,undefined
[11] “Federico II”,undefined
[12] University of Naples Parthenope,undefined
来源
Journal of Neurology | 2018年 / 265卷
关键词
Parkinson’s disease; Gait; Cognition; Gait analysis; Executive dysfunction;
D O I
暂无
中图分类号
学科分类号
摘要
Cognition and gait appear to be closely related. The chronological interplay between cognitive decline and gait dysfunction is not fully understood. The aim of the present prospective study is investigating whether the dysfunction of specific gait parameters, during specific task and medication conditions, may predict subsequent cognitive impairment in Parkinson’s disease (PD). We evaluated cognition and gait in 39 Parkinsonian patients at an initial assessment and after 3 years. Cognitive performance was evaluated with a neuropsychological battery designed to assess memory, executive/attention, and visuospatial domains. Gait was investigated using a gait analysis system during both the off and on states in the following conditions: (1) normal gait; (2) motor dual task; and (3) cognitive dual task. We used regression models to determine whether gait predicts subsequent cognitive dysfunction. Overall, the cognitive test scores were stable over time with the exception of the executive/attention scores, whereas all gait parameters declined. The step length during the cognitive dual task during the on state at the initial evaluation was the only significant predictor of executive/attention domain dysfunction at follow up. The results were confirmed when executive/attention dysfunction at the initial assessment evaluation was included in the regression model as a covariate. Our longitudinal study offers additional insight into the progression of gait dysfunction, and its chronological relationship with cognitive dysfunction in PD patients. In particular, the present study indicates that step length during a cognitive task when on medication is an independent predictor of future executive/attention decline.
引用
收藏
页码:2211 / 2220
页数:9
相关论文
共 225 条
[1]  
Barone P(2011)Cognitive impairment in nondemented Parkinson’s disease Mov Disord 26 2483-2495
[2]  
Aarsland D(2005)Cognitive profile of patients with newly diagnosed Parkinson disease Neurology 65 1239-1245
[3]  
Burn D(2016)Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease Mov Disord 31 861-881
[4]  
Emre M(2000)Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study J Am Geriatr Soc 48 938-942
[5]  
Kulisevsky J(2002)Longevity increased by positive self-perceptions of aging J Pers Soc Psychol 83 261-633
[6]  
Weintraub D(2014)What can biomarkers tell us about cognition in Parkinson’s disease? Mov Disord 29 622-1533
[7]  
Muslimović D(2013)Cognitive contributions to gait and falls: evidence and implications Mov Disord 28 1520-889
[8]  
Post B(2003)Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study Mov Disord 18 884-1130
[9]  
Speelman JD(2006)Changes in motor subtype and risk for incident dementia in Parkinson’s disease Mov Disord 21 1123-1913
[10]  
Schmand B(2005)Visual dysfunction in Parkinson disease without dementia Neurology 65 1907-2189